118 related articles for article (PubMed ID: 18429005)
1. Reversible features of cervical cancer in human immunodeficiency virus infection: impaired access, impaired surveillance, impaired immunity, impaired outcomes.
Little RF; Denicoff AM; Trimble EL
Cancer; 2008 Jun; 112(12):2627-30. PubMed ID: 18429005
[No Abstract] [Full Text] [Related]
2. Vaccines. Can vaccines against HPV work in PHAs?
TreatmentUpdate; 2005; 17(1):12-4. PubMed ID: 17228461
[No Abstract] [Full Text] [Related]
3. Herd immunity.
O'Connor K
Aust Fam Physician; 2007 Sep; 36(9):677. PubMed ID: 17915372
[No Abstract] [Full Text] [Related]
4. Cervical cancer: the second-generation vaccines move forward.
Tuma RS
J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
[No Abstract] [Full Text] [Related]
5. Cervical neoplasia and highly active antiretroviral therapy.
Xi LF; Kiviat NB
J Natl Cancer Inst; 2004 Jul; 96(14):1051-3. PubMed ID: 15265960
[No Abstract] [Full Text] [Related]
6. Primary and secondary prevention of cervical cancer--opportunities and challenges.
Markowitz LE; Unger ER; Saraiya M
J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
[No Abstract] [Full Text] [Related]
7. Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time.
Bosch FX
J Natl Cancer Inst; 2009 Jun; 101(11):771-3. PubMed ID: 19470950
[No Abstract] [Full Text] [Related]
8. Human papillomavirus, cervical cancer prevention, and more.
Lowy D
Vaccine; 2008 Aug; 26 Suppl 10():iii-iv. PubMed ID: 18847562
[No Abstract] [Full Text] [Related]
9. The pediatrician's role in preventing cervical cancer.
Blatter MM; Monk BJ
Clin Pediatr (Phila); 2008 Sep; 47(7):627-38. PubMed ID: 18698095
[No Abstract] [Full Text] [Related]
10. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
[TBL] [Abstract][Full Text] [Related]
11. Vaccine treats cervical cancer.
Radiol Technol; 2008; 79(6):579-81. PubMed ID: 18650537
[No Abstract] [Full Text] [Related]
12. The economic impact of HPV vaccines: not just cervical cancer.
Myers ER
Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522
[No Abstract] [Full Text] [Related]
13. Human papillomavirus vaccines: an outsider's point of view.
Trollfors B
Expert Rev Vaccines; 2008 Oct; 7(8):1131-3. PubMed ID: 18844585
[No Abstract] [Full Text] [Related]
14. The new era of cervical cancer prevention: HPV vaccination.
Monk BJ; Herzog TJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S1-3. PubMed ID: 18482553
[No Abstract] [Full Text] [Related]
15. Policy debate over human papillomavirus vaccines.
Richman S
J Low Genit Tract Dis; 2009 Apr; 13(2):128. PubMed ID: 19387138
[No Abstract] [Full Text] [Related]
16. [Human papilloma virus and cervical cancer].
Berumen-Campos J
Gac Med Mex; 2006; 142 Suppl 2():51-9. PubMed ID: 19031679
[TBL] [Abstract][Full Text] [Related]
17. Preventing cervical cancer: pediatricians role.
Choudhury P
Indian Pediatr; 2009 Mar; 46(3):201-3. PubMed ID: 19346566
[No Abstract] [Full Text] [Related]
18. [Proctology and human immunodeficiency virus].
Puy-Montbrun T
Gastroenterol Clin Biol; 1995; 19(5 Pt 2):B145-9. PubMed ID: 8522095
[No Abstract] [Full Text] [Related]
19. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer.
Palmer KE; Jenson AB; Kouokam JC; Lasnik AB; Ghim SJ
Exp Mol Pathol; 2009 Jun; 86(3):224-33. PubMed ID: 19454268
[TBL] [Abstract][Full Text] [Related]
20. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme].
de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259
[No Abstract] [Full Text] [Related]
[Next] [New Search]